Themis Medicare Ltd
Themis Medicare | 530199
Share Price Chart - Themis Medicare Ltd
Stock Performance
Ratios
About Company
- Themis Medicare Limited was formerly incorporated as 'Themis Chemicals Limited' in 1969
- The Company was originally promoted by Chemosyn and Medimpex but was taken over by a Group consisting of Shantibhai D Patel and K T Lakdawala who also have interests in Andhra Synthetics and Antibiotics, which was merged with Artemis Pharmaceuticals in April, 1993
- Thereafter, the name of the Company was changed to Themis Medicare Limited in 2001
- The Company is principally engaged in the business of manufacturing of finished formulations and
- synthetic Active Pharmaceutical Ingredients
- '95, the company came out with a public issue equity shares (premium : Rs 110) to finance the expansion-cum-modernisation of its synthetic bulk drug plant at Vapi, the setting up of a formulation unit at Lilora, Baroda as backward integration and to augment long-term working capital
- Total cost of the project was estimated at Rs 17
- TCL manufactures and sells synthetic bulk drugs and formulations
- It operates in the therapeutic segments of anti-tuberculosis, cerebroactivators, bronchodilators, anti-asthmatic, anaesthetic and other segments
- Anti-tuberculosis bulk drugs and formulations account for 60% of its turnover and the company is rated fourth in terms of turnover in this segment
Ethics: Themis Medicare Ltd is flagged for
Adequate
---
Research Calls
Technical Indicators
Pivot Points
Volume Analysis
Growth Rate
All figures in ₹ Crores
No Information Available
No shareholding data available at this time.
No Data Available
No Block Deals data available for this company.
News
No Information Available
Peers
#IndiaInvests
Trusted by 2.5 lac + Indians for their wealth-building needs
Invest in stocks with ease
Open your account in less than 10 mins*
By proceeding, you agree to all T&C *
Top Gainers
Frequently Asked Questions
What is Share Price of Themis Medicare Ltd?
The current share price of Themis Medicare Ltd (Themis Medicare) is ₹116.96. This price reflects the latest market valuation and is updated in real-time during trading hours.
What is the P/E Ratio of Themis Medicare Ltd?
The Price-to-Earnings (P/E) ratio of Themis Medicare Ltd is 116.96. This indicates how much investors are willing to pay per rupee of earnings, helping assess if the stock is overvalued or undervalued.
What is the 52-week high and low of Themis Medicare Ltd?
Themis Medicare Ltd has a 52-week high of ₹148.00 and a 52-week low of ₹64.95. This range shows the stock's price volatility over the past year.
What is the Dividend Yield of Themis Medicare Ltd?
Themis Medicare Ltd offers a dividend yield of 0.43%. This represents the annual dividend payment as a percentage of the current stock price, indicating the income return for investors.
What is the EPS of Themis Medicare Ltd?
The Earnings Per Share (EPS) of Themis Medicare Ltd is ₹0.18. EPS indicates the company's profitability on a per-share basis and is a key metric for evaluating financial performance.
What is the ROE of Themis Medicare Ltd?
Themis Medicare Ltd has a Return on Equity (ROE) of 8.62%. ROE measures how effectively the company uses shareholders' equity to generate profits, with higher values generally indicating better performance.
Disclaimer:
Please note that the above list and information is for research purposes only and are not recommendations. Do your own due diligence or consult an investment advisor before investing. The above data is dynamic in nature and subject to real-time changes and is derived from CMOTS.
